Fig. 2From: Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotectionSarcolemmal phospholipid signaling via phospholipases. AA arachidonic acid, DAG 1,2-diacylglycerol, IP3 inositol 1,4,5-triphosphate, PA phosphatidic acid, PC phosphatidylcholine, PIP 2 phosphatidylinositol-4,5-bisphosphate, PLA 2 phospholipase A2, PLC phospholipase C, PLD phospholipase DBack to article page